| Symbol | PMCB |
|---|---|
| Name | PHARMACYTE BIOTECH, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 3960 HOWARD HUGHES PARKWAY, LAS VEGAS, NV 89169 |
| Telephone | (917) 595.2850 |
| Fax | — |
| — | |
| Website | https://pharmacyte.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001157075 |
| Description | PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer. Additional info from NASDAQ: |
Director WEINSTEIN ROBERT 🟢 acquired 119.2K shares (1 derivative) of PharmaCyte Biotech, Inc. (PMCB) at $0.67 Transaction Date: Mar 31, 2026 | Filing ID: 002633
Read moreDirector SCHECHTER JONATHAN 🟢 acquired 119.2K shares (1 derivative) of PharmaCyte Biotech, Inc. (PMCB) at $0.67 Transaction Date: Mar 31, 2026 | Filing ID: 002631
Read moreDirector Abecassis Michael M 🟢 acquired 119.2K shares (1 derivative) of PharmaCyte Biotech, Inc. (PMCB) at $0.67 Transaction Date: Mar 31, 2026 | Filing ID: 002630
Read more(99% Neutral) PHARMACYTE BIOTECH, INC. (PMCB) Announces Executive Changes
Read moreNew Form ARS - PharmaCyte Biotech, Inc. <b>Filed:</b> 2026-03-09 <b>AccNo:</b> 0001683168-26-001600 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - PharmaCyte Biotech, Inc. <b>Filed:</b> 2026-03-09 <b>AccNo:</b> 0001683168-26-001593 <b>Size:</b> 2 MB
Read moreNew Form PRE 14A - PharmaCyte Biotech, Inc. <b>Filed:</b> 2026-02-27 <b>AccNo:</b> 0001683168-26-001363 <b>Size:</b> 1 MB
Read moreNew Form SCHEDULE 13G/A - PharmaCyte Biotech, Inc. <b>Filed:</b> 2026-02-13 <b>AccNo:</b> 0001213900-26-016526 <b>Size:</b> 17 KB
Read moreDirector Silverman Joshua 🟢 acquired 100.0K shares of PharmaCyte Biotech, Inc. (PMCB) at $0.83 Transaction Date: Jan 05, 2026 | Filing ID: 000148
Read moreDirector SCHECHTER JONATHAN 🟢 acquired 60.0K shares of PharmaCyte Biotech, Inc. (PMCB) at $0.84 Transaction Date: Jan 05, 2026 | Filing ID: 000147
Read more